TREM2 and lung carcinoma: In addition, TREM2 KO monocyte-injected mice had smaller tumor volumes and weights and slower tumor growth than those of WT monocyte-injected mice (Fig. 5C and E), suggesting that TREM2 loss-of-function myeloid cells inhibit lung cancer progression.